Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-02879-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Jia Jian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China. Hauptthemen laut MEDLINE: Piperidines, Alopecia Areata, Pyrimidines, Drugs, Generic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
- Hu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China. 1012797233@qq.com.
- Hu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China. shiwei@csu.edu.cn.
Zitieren
APA
Jian, J., Li, M., Qian, P., Li, J., Tang, Y., Liu, F., Zhao, Z., Huang, J., & Shi, W. (2024). Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-02879-4
Vancouver
Jian J, Li M, Qian P, Li J, Tang Y, Liu F, et al. Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-02879-4
BibTeX
@article{Jian2024,
author = {Jian, Jia and Li, Min and Qian, Pei and Li, Ji and Tang, Yan and Liu, Fangfen and Zhao, Zhixiang and Huang, Jundong and Shi, Wei},
title = {Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-02879-4}
}
EUVIMED